DYRK1A and diabetes mellitus: In conclusion, we demonstrated that miR-221-3p inhibited the inflammatory response and promoted skin wound healing in diabetes by targeting DYRK1A expression and then regulating the DYRK1A/STAT3 signaling pathway.